CG
TMDX icon

Cynosure Group’s Transmedics TMDX Stock Holding History

Cynosure Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Buy
+3,036
New +$396K 0.04% 183

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cynosure Group's TMDX Position: Q1 2026 in Review

Cynosure Group opened a new position in Transmedics (TMDX) in Q1 2026: 3,036 shares worth $302K. The stake represents 0.04% of the portfolio and ranks #183 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Cynosure Group held 3,036 shares of Transmedics worth $302K as of Q1 2026.
  • Transmedics was a new Cynosure Group position in Q1 2026.
  • Transmedics made up 0.04% of Cynosure Group's portfolio in Q1 2026, its #183 holding.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.